A. Gogoll et al.
3
3J(H,H)=6.8 Hz, 2H; CH2), 2.86 (t, J(H,H)=6.8 Hz, 2H; CH2), 5.17 (d,
ethyl acetate (2:1) eluent mixture, yielding a white solid (887.7 mg,
1.67 mmol, 82%). 1H NMR (399.8 MHz, CDCl3, 2 85C): d=2.67 (t,
3J(H,H)=7.7 Hz, 2H; CH2), 2.86 (t, 3J(H,H)=6.7 Hz, 2H; CH2), 2.98 (t,
3J(H,H)=7.7 Hz, 2H; CH2), 3.50 (dt, 3J(H,H)=6.7, 6.9 Hz, 2H; CH2),
3.69 (s, 3H; CH3), 4.22 (t, 3J(H,H)=6.8 Hz, 1H; Fmoc-CH), 4.41 (d,
3J(H,H)=6.8 Hz, 2H; Fmoc-CH2), 4.88 (t, 3J(H,H)=6.9 Hz, 1H; NH),
7.09 (m, 2H; CH), 7.11 (d, 3J(H,H)=7.3 Hz, 2H; ArH), 7.25–7.35 (m,
3J(H,H)=10.8 Hz, 1H; CH), 5.68 (d, 3J(H,H)=17.6 Hz, 1H; CH), 6.63
(dd, 3J(H,H)=10.8, 17.6 Hz, 1H; CH), 7.00 (d, 3J(H,H)=6.2Hz, 1H;
ArH), 7.15–7.20 ppm (m, 3H; ArH); 13C NMR (100.5 MHz, CDCl3,
258C): d=40.1, 43.6, 113.8, 124.1, 126.8, 128.4, 128.7, 136.9, 137.7,
140.2ppm; MS (30 eV, ESI): m/z (%): 189, 148 [M+H]+.
[2-(3-Vinylphenyl)ethyl]carbamic acid tert-butyl ester(10) : 2-(3-Vinyl-
phenyl)ethylamine (950.0 mg, 6.50 mmol) and di-tert-butyl dicarbonate
(1.55 g, 7.10 mmol) were dissolved in CH2Cl2 (20 cm3) and mixed with
aqueous potassium carbonate (20 cm3, 2.68 g, 19.4 mmolK2CO3). The het-
erogeneous mixture was rigorously stirred for 24 h, and the organic phase
was then separated, filtered through MgSO4, and concentrated. The resi-
due was purified by column chromatography with a hexane/ethyl acetate
(9:1) eluent mixture, yielding a colorless oil (113.5 mg, 4.5 mmol, 70%).
1H NMR (399.8 MHz, CDCl3, 2 58C): d=1.43 (s, 9H; CH3Boc), 2.78 (t,
3J(H,H)=6.9 Hz, 2H; CH2), 3.36 (t, 3J(H,H)=6.9 Hz, 2H; CH2), 4.61
(brs, 1H; NH), 5.26 (d, 3J(H,H)=11.0 Hz, 1H; CH), 5.74 (d, 3J(H,H)=
17.6 Hz, 1H; CH), 6.69 (dd, 3J(H,H)=11.0, 17.6 Hz, 1H; CH), 7.08 (d,
3J(H,H)=6.0 Hz, 1H; ArH), 7.22–7.29 ppm (m, ArH3H;); 13C NMR
(100.5 MHz, CDCl3, 2 58C): d=28.5 (3C), 36.2, 41.8, 79.3, 114.0, 124.4,
126.8, 128.4, 128.8, 136.8, 137.9, 139.3, 156.0 ppm; MS (30 eV, ESI): m/z
(%): 495 [2M+H]+ 405, 289, 248 [M+H]+, 233.
3
8H; ArH), 7.39 (t, J(H,H)=7.3 Hz, 2H; Fmoc-ArH), 7.58 (d, 3J(H,H)=
7.5 Hz, 2H; Fmoc-ArH), 7.76 ppm (d, 3J(H,H)=7.5 Hz, 2H; Fmoc-
ArH); 13C NMR (100.5 MHz, CDCl3, 2 58C): d=31.0, 35.7, 36.3, 42.3,
47.4, 51.8, 66.7, 120.1, 124.7, 124.9, 125.2, 126.6, 127.1, 127.2, 127.7, 127.8,
128.3, 128.6, 128.9, 129.0, 129.1, 137.6, 137.8, 139.3, 141.0, 141.4, 144.1,
156.4, 173.4 ppm; MS (30 eV, ESI): m/z (%): 1063.1 (22) [2M+H]+, 532.1
(100) [M+H]+.
trans-3-{3-{2-{3-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethyl]phe-
nyl}vinyl}phenyl}propionic acid (14): Compound 17 (106.0 mg,
0.20 mmol), dissolved in dichloromethane (4.5 cm3), was added to con-
centrated aqueous HCl solution (40 cm3) and was heated at reflux at
1208C for 22 h. The mixture was then extracted with dichloromethane,
and the organic phase was separated, filtered through MgSO4, and con-
centrated under reduced pressure, yielding
a white solid (639.4 mg,
1.24 mmol, 91%). 1H NMR (399.8 MHz, CD3CN, 258C): d=2.63 (t,
3J(H,H)=8.0 Hz, 2H; CH2), 2.85 (t, 3J(H,H)=7.0 Hz, 2H; CH2), 2.92 (t,
3J(H,H)=8.0 Hz, 2H; CH2), 3.42(brt, 3J(H,H)=7.0 Hz, 2H; CH2), 4.20
(t, 3J(H,H)=7.0 Hz, 1H; Fmoc-CH), 4.31 (d, 3J(H,H)=7.0 Hz, 2H;
Fmoc-CH2), 7.13 (d, 3J(H,H)=7.7 Hz, 1H; ArH), 7.16 (d, 3J(H,H)=
7.7 Hz, 1H; ArH), 7.22 (m, 2H; CH), 7.27 (t, 3J(H,H)=7.7 Hz, 2H;
Methyl trans-3-{3-{2-[3-(2-tert-butoxycarbonylaminoethyl)phenyl]vinyl}-
phenyl}propionate (11): A mixture of 10 (90.0 mg, 0.3 mmol), 8 (80.2mg,
0.33 mmol), Pd(OAc)2 (3.4 mg, 15.0 mmol), tri-o-tolyl-phosphine (9.1 mg,
30.0 mmol), and triethylamine (0.10 cm3, 0.90 mmol) in dimethylform-
amide (1.50 cm3) was stirred in a Smith Process Vial at 1208C for 30 min
in the microwave cavity. The resulting mixture was filtered through
Celite into a separation funnel. Dichloromethane (25 cm3) was added,
3
ArH), 7.29 (t, J(H,H)=7.3 Hz, 2H; ArH), 7.38 (t, 3J(H,H)=7.3 Hz, 2H;
3
ArH), 7.43 (d, J(H,H)=7.7 Hz, 2H; ArH), 7.48 (2brs, 2H; ArH), 7.66
(d, 3J(H,H)=7.3 Hz, 2H; Fmoc-ArH), 7.83 ppm (d, 3J(H,H)=7.3 Hz,
2H; Fmoc-ArH); 13C NMR (100.5 MHz, CD3CN and 1 drop of CD3OD,
258C): d=30.7, 35.1, 35.9, 42.1, 47.3, 65.9, 120.0, 124.4, 124.5, 125.3,
126.6, 127.0, 127.1, 127.6, 127.7, 127.72, 128.2, 128.6, 128.63, 128.8, 137.6,
137.7, 140.0, 141.3, 141.6, 144.4, 156.4, 173.2ppm; MS (30 eV, ESI): m/z
(%): 1035.0 (14) [2M+H]+, 518.1 (1) [M+H]+.
3
and the organic phase was extracted with HCl (1.0m, 2 5 cm) and concen-
trated aqueous NaHCO3 solution, the aqueous phase being reextracted
twice. The combined organic layers were filtered through MgSO4 and
concentrated under reduced pressure. The residue was purified by
column chromatography with a hexane/ethyl acetate eluent mixture with
a gradient of 9:1 to 1:1, yielding a white precipitate (53.1 mg, 0.13 mmol,
43%). M.p.=80–828C (from EtOAc); 1H NMR (399.8 MHz, CDCl3,
258C): d=1.45 (s, 9H; CH3Boc), 2.66 (t, 3J(H,H)=7.6 Hz, 2H; CH2), 2.69
(brt, 3J(H,H)=6.9 Hz, 2H; CH2), 2.96 (t, 3J(H,H)=7.6 Hz, 2H; CH2),
3.40 (brt, 3J(H,H)=6.9 Hz, 2H; CH2), 3.68 (s, 3H; CH3), 4.60 (brs, 1H;
NH), 7.08 (m, 2H; CH), 7.10 (d, 3J(H,H)=7.3 Hz, 2H; ArH), 7.27 (dt,
3J(H,H)=2.2, 7.6 Hz, 2H; ArH), 7.33–7.40 ppm (m, 4H; ArH); 13C NMR
(100.5 MHz, CDCl3, 2 58C): d=28.5 (3C), 31.0, 35.8, 36.3, 41.8, 51.7, 79.3,
124.6, 124.8, 126.6, 127.0, 127.7, 128.2, 128.7, 128.8, 128.9, 129.0, 137.6,
137.7, 139.5, 141.0, 156.0, 173.4 ppm; IR (CHCl3): n˜max =3446, 3055, 2984,
1725, 1433, 1262 cmÀ1; MS (30 eV, ESI): m/z (%): 819 [2M+H]+, 410
[M+H]+, 354.
(C2H5)2N-(CH2)2CO-Leu-Ala-Thr-Thr-DPro-Gly-Ile-Val-Leu-Leu-NH2
(1): 84.4 mg, 75 mmol, 20.6%; [a]D =À73.58 (methanol, 178C, pH 3.2);
MS (ESI, 30 eV) m/z (%): 1123.4 (11) [M+H]+, 562.6 (100) [M+2H] +
;
D=0.9010À6 cm2 sÀ1 ([D6]DMSO, 258C); amino acid analysis: Thr 2.01,
Pro 1.03, Gly 1.03, Ala 1.01, Val 0.93, Ile 0.93, Leu 3.05 (71% peptide).
trans-(C2H5)2N-(CH2)2CO-Leu-Ala-Thr-Thr-(CH2)2PhCH=CHPh(CH2)2-
Ile-Val-Leu-Leu-NH2 (2): 29.9 mg, 24 mmol, 6.6%; [a]D =À64.38 (metha-
nol, 198C, pH 3.0); D=0.710À6 cm2 sÀ1 ([D6]DMSO, 258C); MS (ESI,
30 eV) m/z (%): 1246.7 (17) [M+H]+, 624.5 (100) [M+2H] +; amino acid
analysis: Thr 2.08, Ala 1.00, Val 0.90, Ile 0.89, Leu 3.00 (71% peptide).
cis-(C2H5)2N-(CH2)2CO-Leu-Ala-Thr-Thr-(CH2)2PhCH=CHPh(CH2)2-
Ile-Val-Leu-Leu-NH2 (3): Quantum yield=2.9%; MS (ESI, 30 eV) m/z
(%): 1246.7 (0.5) [M+H]+, 624.5 (100) [M+2H] +; D=0.710À6 cm2 sÀ1
([D6]DMSO, 258C).
Methyl
trans-3-{3-{2-[3-(2-aminoethyl)phenyl]vinyl}phenyl}propionate
(12): Compound 11 (202.5 mg, 0.49 mmol) was mixed with trifluoroacetic
acid in dichloromethane (50%) and stirred for 15 min. The solution was
then concentrated under reduced pressure, yielding
a yellowish oil
trans-Cyclo(-DPro-Gly-Leu-Ala-Thr-Thr-(CH2)2PhCH=CHPh(CH2)2-Ile-
(202.5 mg, 6.55 mmol, 93%). 1H NMR (399.8 MHz, CDCl3, 2 58C): d=
2.72 (t, 3J(H,H)=7.7 Hz, 2H; CH2), 2.96 (t, 3J(H,H)=7.7 Hz, 2H; CH2),
3.02(t, 3J(H,H)=7.4 Hz, 2H; CH2), 3.41 (brt, 3J(H,H)=7.4 Hz, 2H;
Val-Leu-Leu-) (4): [a]1D9 =À42.9 (methanol); MS (30 eV, ESI): m/z (%):
1256.4 (17) [M+H]+, 629.1 (100) [M+2H]2+
;
D=1.410À6 cm2 sÀ1
([D6]DMSO, 258C); amino acid analysis: Thr 2.01, Pro 1.06, Gly 1.03,
Ala 0.96, Val 0.99, Ile 0.94, Leu 3.01 (54% peptide).
cis-Cyclo(-DPro-Gly-Leu-Ala-Thr-Thr-(CH2)2PhCH=CHPh(CH2)2-Ile-
Val-Leu-Leu-) (5): Quantum yield=1.2% (300 nm); [a]1D9 =À66.8 (meth-
anol); MS (30 eV, ESI): m/z (%): 1256.4 (17) [M+H]+, 629.1 (100)
[M+2H] +; D=1.810À6 cm2 sÀ1 ([D6]DMSO, 258C).
CH2), 3.72(s, 3H; CH ), 6.91 (brs, 2H; NH2), 7.06 (m, 2H; CH), 7.08 (d,
3
3J(H,H)=7.3 Hz, 2H; ArH), 7.25–7.32 (m, 4H; ArH), 7.34 (t, 3J(H,H)=
7.7 Hz, 1H; ArH), 7.43 (d, 3J(H,H)=7.7 Hz, 1H; ArH), 12.10 ppm (brs,
1H; COOH); 13C NMR (100.5 MHz, CDCl3, 2 58C): d=30.9, 33.2, 35.9,
42.0, 52.7, 124.9, 126.1, 126.5, 126.8, 127.7, 127.8, 128.0, 129.1, 129.4,
129.8, 135.1, 137.4, 138.5, 140.3, 176.5 ppm; MS (30 eV, ESI): m/z (%):
620.1 (1.4) [2M+H]+, 310.1 (100) [M+H]+.
Photoisomerization: Photochemical reactions were performed in dimeth-
yl sulfoxide under N2 gas flow with use of an Oriel 1000 W Xe ARC light
source and a 300 nm or a 280 nm Oriel UV filter. The emitted light inten-
sity was determined at the wavelengths of isomerizations (280 or 300 nm)
with use of a UV enhanced Silica photodiode (5.8 mm2) attached to a cur-
rent meter.
Methyl trans-3-{3-{2-{3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]-
phenyl}vinyl}phenyl}propionate
(13):
Compound
12
(630.4 mg,
2.04 mmol) and 9-fluorenylmethyl chloroformate (582.3 mg, 2.25 mmol)
were dissolved in a mixture of dioxane (30 cm3) and aqueous Na2CO3 so-
lution (10%), and the mixture was stirred for 17 h at room temperature.
The mixture was then extracted with CH2Cl2, and the organic phase was
separated, filtered through MgSO4, and concentrated under reduced pres-
sure. The residue was purified by column chromatography with a hexane/
NMR measurements: NMR spectra were recorded on Varian INOVA
(1H at 499.9 MHz), Jeol EX-400 (1H at 399.8, and 13C at 100.5 MHz), or
Jeol EX-270 (1H at 270.2, and 13C at 67.5 MHz) spectrometers. Signal as-
410
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2006, 12, 403 – 412